Hariprasad Vankayalapati

Company: Biolexis Therapeutics

Job title: Chief Scientific Officer

Seminars:

Design & Development of Novel GPCR Targeting Small Molecule Agonists with the Application of Quenched Molecular Dynamic (QMD) Simulations 2:00 pm

Generation of physiologicaly relevant conformers, binding mode, design of peptidomimetics by constraining peptide backbone, we develop orally available peptide or small molecules Further profiling against several GPCR family member target proteins for selectivity and stability for targeted treatment Generate natural peptide sequence to a stable conformer, search for amide back-bone, alpha-C, acid and amine mimetic…Read more

day: Conference Day One

Fireside Chat: Examining the Future Possibilities of Modalities for GPCRTargeted Drugs to Become More Effective & Feasible 4:00 pm

Can we develop orally available peptides? How do you make a peptidic starting point into a small molecule? What are the different modalities that can be employed to target different GPCRs?Read more

day: Conference Day One